Transpek Industry Limited · BSE:TRANSPEK
Transpek Industry — Investor Presentation (December 2021)
40 slides from Transpek Industry's investor presentation, Dec 8, 2021
Slide 1: Cover letter to BSE on investor presentation
+91 265 2335444, 2335757, 2358236 2342262, 2334141 I PH O NE +9 1 2 6 5 2 3 3 5 7 5 8 F A X, - li,a n sp e" Transpek Industry Umited I ..... Off: 4111 Floor, Uleria 1038, Gotri Sevasi Road. 1111111111111' Vadodara - 390021. Gujarat (India) reative Chemls,ry Ph. : 0265�700300 • 301 Date: 8th December
Slide 2: Transpek Industry Limited Investor Presentation December 2021
Transpek Industry Limited Investor Presentation December 2021
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Transpek Industry Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se
Slide 4: Q2 FY22 - Financial Highlights
Q2 FY22 - Financial Highlights
Slide 5: Business Highlights
Business Highlights Business performance has seen a significant improvement over the last two quarters. The revenues in H1FY22 were better as compared to the same period last year. The application volumes are gradually restoring providing opportunity for the company to increase its revenues. As a st
Slide 6: Sequential Improvement in Performance
Sequential Improvement in Performance Q2 FY22 Sales Distribution based on Revenue* (Rs. In Cr) Application 13.2% Polymer 158.4 11.2% Pharma 132.0 11.8% 63.9% Specialty 95.7 101.2 Others 79.6 80.3 Q2 FY22 - Revenue Breakup Q1FY21 Q2FY21 Q3FY21 Q4FY21 Q1 FY22 Q2 FY22 22.3% International EBITDA* (Rs. I
Slide 7: Sequential Improvement in Performance
Sequential Improvement in Performance H1 FY22 Sales Distribution based on Revenue* (Rs. In Cr) Application 13.4% Polymer 290.4 12.9% Pharma 60.9% Specialty 12.8% Others 159.8 H1 FY22 - Revenue Breakup H1 FY21 H1 FY22 23.3% International EBITDA* (Rs. In Cr) PAT (Rs. In Cr) Domestic 76.7% Margin 14.6%
Slide 8: Q2FY22 - Consolidated Profit & Loss Account
Q2FY22 - Consolidated Profit & Loss Account Particulars (Rs. Crores) Q2FY22 Q2FY21 Y-o-Y H1FY22 H1FY21 Y-o-Y Revenue from Operations 154.7 77.3 276.4 151.9 Other Income 3.8 3.0 14.0 7.9 Total Revenue from operations 158.4 80.2 97.4% 290.4 159.8 81.7% Cost of materials consumed 90.8 41.7 155.1 74.5 P
Slide 9: Sep'21 - Consolidated Balance Sheet
Sep’21 - Consolidated Balance Sheet Liabilities (Rs. Crores) Sep-21 Mar-21 Assets (Rs. Crores) Sep-21 Mar-21 Equity Non Current assets Equity Share capital 5.6 5.6 Property, Plant and Equipment 268.0 271.5 Other Equity 431.2 374.2 Capital work-in-progress 18.6 13.9 Right to use of lease assets 12.0
Slide 10: Sep'21 - Consolidated Cash Flow Statement
Sep’21 - Consolidated Cash Flow Statement Particulars (Rs. Crores) Sep-21 Sep-20 Net Profit Before Tax 43.0 4.1 Adjustments for: Non Cash Items / Other Investment or Financial Items 21.4 15.5 Operating profit before working capital changes 64.4 19.6 Changes in working capital -6.7 26.6 Cash generate
Slide 11: FAQ's
FAQ’s • The management periodically reviews the situation and would announce any significant change in the status. Project & Capex • The Capex for next two years will be based on the timing of the introduction of new products and any significant investment will be announced appropriately. Logistic &
Slide 12: Transpek at Glance
Transpek at Glance
Slide 13: About us
About us Environment Protection Founded by Shri. Govindji Shroff in 1965 Over 5 decades Creative Over three Part of Excel experience in Chemistry decades of presence in the group of Sulphur and international companies Chlorine market Chemistry Customer Exploring every Headquartered Focus possible in
Slide 14: Our journey over five decades
Our journey over five decades 2017 Long term supply agreement with global chemical giant 2018 Started supplying under long 2004 term supply agreement and Set up of First Multi Purpose became big global player in acid Acid Chloride Plant chlorides 2012 1987 Significant strategic shift from Started ma
Slide 15: Our products are supplied to varied industries
Our products are supplied to varied industries Leading global supplier for ‘Chlorinated Products’ to various industry sectors FY21 Sales Distribution based on Application ranging from Pharmaceuticals, Agrochemicals and dyes to pigments. Polymers Pharma Specialty Chemicals 7.1% 11.8% Polymer Pharma S
Slide 16: Our products have multiple applications
Our products have multiple applications Diversified Products Across India’s Fastest Growing Industries • 2, 4, 6 Trimethyl Benzoyl • 2-Methoxyethyl chloride • 2-Chloroethylamine • 2-Chloroethylamine Chloride • Cocoyl Chloride • 2-Propoxyethyl chloride Hydrochloride Solution Hydrochloride Solution •
Slide 17: Our capabilities developed over years
Our capabilities developed over years Research & Development Sustainability Ratings ◊ In house development of products ◊ ECOVADIS Sustainability platform – the company is ◊ DSIR approved R&D Facility rated very high with ‘Silver Badge’ ◊ R&D Lab approved by MS University of Baroda for ◊ One of those
Slide 18: Our clients trust in our capabilities & chemistries
Our clients trust in our capabilities & chemistries Company has built an excellent reputation globally – Testament to our Reliability and Trustworthiness Long-term supply agreement commenced from 1st January 2018 Contract 10 years Period Exclusive contract with a High performance product with dedica
Slide 19: Our plants are multipurpose and multiproduct
Our plants are multipurpose and multiproduct Ekalbara Located ~25 km away from the headquarter location at Vadodara, Gujarat. Dedicated multipurpose and multiproduct plants spread over 100 acres with total production capacity of 66,000 • Strategically located in largest chemical MTPA. manufacturing
Slide 20: Our R & D facility is recognized by Government of India
Our R & D facility is recognized by Government of India Research & Development Developed a comprehensive in-house R&D facility recognized by the Department of Science & Technology, Government of India, which is equipped with latest technology and equipment Every new and existing product undergoes a
Slide 21: Our top management is committed to process safety
Our top management is committed to process safety PHA Chemical Release • Process Hazard Analysis 01 • Dispersion Modeling Studies conducted for all products and • Storage Quantity Reduction processes 02 • Mechanical Integrity of Equipment Top Management 06 PSSR • Total commitment and • Pre-Startup s
Slide 22: Our transportation is safe, systematic and sustainable
Our transportation is safe, systematic and sustainable Logistics Safe, systematic and sustainable transportation is a key challenge to ever changing global chemical industry Pioneers in developing in-house ISO Tank station which is well equipped with state-of-the-art technology We manage over 600 IS
Slide 23: Our products are delivered across the globe
Our products are delivered across the globe One of the Pioneering Global Exporters from India since 1986 FY21 - Revenue Breakup Long term relations with Leading Global Chemical Giants 25% Sweden 75% Spain Germany Russia France Italy Switzerland Domestic International U.S.A. Japan China South Korea T
Slide 24: Our board has vast industry experience
Our board has vast industry experience Mr. Ashwin C. Shroff | Chairman Mr. Bernd Dill | Independent Director He is a science graduate, Mr. Shroff have emerged stronger, helping the growth of He is a German national, having emphasis on mathematics and natural sciences, Doctoral Industrial chemicals,
Slide 25: Appointed Mr. Avtar Singh as Joint Managing Director
Appointed Mr. Avtar Singh as Joint Managing Director Our Board at its meeting held on 22nd September, 2021, has approved the appointment of Shri Avtar Singh as a Whole-time Director of the Company designated as Joint Managing Director for a period of 5 (five) years w.e.f 1st October, 2021. Shri Avta
Slide 26: Our company has adopted a sustainable method of doing business
Our company has adopted a sustainable method of doing business Community Empowerment Biodiversity Serving the society in various areas Maintaining and enhancing green belt (flora and like health & hygiene, education, skill fauna) within the factory premises through development, vocational training e
Slide 27: ESG at the heart of all we do
ESG at the heart of all we do
Slide 28: Corporate social responsibility
Corporate social responsibility Women Empowerment Workshops Vocational Training Understanding the needs of communities, addressing them Our vision is to actively contribute towards through need-based projects and making them work together creating innovative and sustainable solutions in to help crea
Slide 29: Awards and Recognitions – A glimpse
Awards and Recognitions – A glimpse Government of Gujarat: FGI Award for Excellence in the field of Indian Chemical Council: Excellence in CSR Award Environment Pollution Abatement & Best in Social Responsibility Award Preservation Shri Atul Shroff MD & Union Leader Shri Ashok Shri Bimal V. Mehta, E
Slide 30: Environment, health and safety
Environment, health and safety Rainwater harvesting and recharging Green cover in Transpek premise Safety is our responsibility We have Full-fledged Effluent management system with a licensed discharge facility to the central Effluent channel Our company has 100 acres of land with a green belt of mo
Slide 31: Socially responsible at the time of COVID – 19
Socially responsible at the time of COVID – 19 Activities done during COVID-19: Arranged for immunity boosting medicines including multi vitamins, zinc and iron sucrose injections, as per the requirements of Primary Health Centre – Mujpur, along with gloves and sanitizer bottles for their health sta
Slide 32: Historical Financial Highlights
Historical Financial Highlights
Slide 33: FY21 – Consolidated Profit & Loss Account
FY21 – Consolidated Profit & Loss Account Particulars (Rs. Crores) FY21 FY20 Y-o-Y Revenue from Operations 339.4 565.6 Other Income 17.3 17.4 Total Revenue from operations 356.7 583.0 -38.8% Cost of materials consumed 159.3 253.1 Purchases of stock-in-trade 0.0 0.0 Changes in inventories of finished
Slide 34: Mar'21 - Consolidated Balance Sheet
Mar’21 - Consolidated Balance Sheet Liabilities (Rs. Crores) Mar-21 Mar-20 Assets (Rs. Crores) Mar-21 Mar-20 Equity Non Current assets Equity Share capital 5.6 5.6 Property, Plant and Equipment 271.5 270.7 Other Equity 374.2 332.9 Capital work-in-progress 13.9 18.6 Right to use of lease assets 15.6
Slide 35: Mar'21 - Consolidated Cash Flow Statement
Mar’21 - Consolidated Cash Flow Statement Particulars (Rs. Crores) Mar-21 Mar-20 Net Profit Before Tax 25.5 93.5 Adjustments for: Non Cash Items / Other Investment or Financial Items 33.6 39.3 Operating profit before working capital changes 59.1 132.8 Changes in working capital 2.4 2.0 Cash generate
Slide 36: Consolidated Financial Highlights
Consolidated Financial Highlights Revenue* (Rs. In Cr) EBITDA* (Rs. In Cr) PAT (Rs. In Cr) 18.6% 15.3% 21.9% 23.2% 18.1% 9.3% 7.1% 10.7% 12.5% 6.5% Margin 612.4 583.0 150 134.4 135.3 80 73.0 65.7 60 370.9 356.7 100 324.0 60.2 56.9 64.4 40 30.0 26.4 23.3 50 20 0 0 FY17 FY18 FY19 FY20 FY21 FY17 FY18 F
Slide 37: Consistent Dividend Performance
Consistent Dividend Performance Dividend Dividend Per Share 220 27 200% 200 180 20.0 160 18 140 125% 120 100 90% 90% 12.5 80 75% 75% 9 60 9.0 9.0 50% 7.5 7.5 40 25% 2.5 5.0 20 0 0 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 36
Slide 38: Way Forward
Way Forward
Slide 39: Strategic Growth
Strategic Growth A two fold approach to growth is being followed by the Company: ▪ First approach is to add products that are similar to current products in chemistry profile but have varied applications. This would help in growing in the areas that are well known by the Company and also the Company
Slide 40: Thank You
Contact Information Company : Investor Relations Advisor : Transpek Industry Limited Strategic Growth Advisors Pvt. Ltd. CIN: L23205GJ1965PLC001343 CIN: U74140MH2010PTC204285 Mr. Alak D. Vyas Mr. Shrikant Sangani / Ms. Pankti Majithia E: shrikant.sangani@sgapl.net / pankti.majithia@sgapl.net E: secr
Transpek Industry — Investor Presentation (December 2021) on 6ix